Patents by Inventor Manjarika De

Manjarika De has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synergistic liposomal formulation for the treatment of cancer
    Patent number: 10426728
    Abstract: The present disclosure relates to the synergistic liposomal formulation comprising, phophatidylcholine, stearylamine and anticancer drugs for the treatment of cancer. The PC:SA cationic liposome encapsulated camptothecin (CPT) and doxorubicin (DOX) formulations show enhanced synergistic anti-cancer effect and provide improved therapeutic index as compared to either the liposome or drug alone. The present disclosure also relates to the use of Cationic liposomal preparation of phosphatidylcholine:stearylamine (PC:SA) showing anticancer effect. The SA-bearing liposome and drug entrapped in the liposome are effective against cancer both in vitro and in vivo, without causing any adverse effect on host.
    Type: Grant
    Filed: September 18, 2014
    Date of Patent: October 1, 2019
    Assignee: Council of Scientific and Industrial Research
    Inventors: Nahid Ali, Manjarika De, Triparna Sen
  • SYNERGISTIC LIPOSOMAL FORMULATION FOR THE TREATMENT OF CANCER
    Publication number: 20160228366
    Abstract: The present disclosure relates to the synergistic liposomal formulation comprising, phophatidylcholine, stearylamine and anticancer drugs for the treatment of cancer. The PC:SA cationic liposome encapsulated camptothecin (CPT) and doxorubicin (DOX) formulations show enhanced synergistic anti-cancer effect and provide improved therapeutic index as compared to either the liposome or drug alone. The present disclosure also relates to the use of Cationic liposomal preparation of phosphatidylcholine:stearylamine (PC:SA) showing anticancer effect. The SA-bearing liposome and drug entrapped in the liposome are effective against cancer both in vitro and in vivo, without causing any adverse effect on host.
    Type: Application
    Filed: September 18, 2014
    Publication date: August 11, 2016
    Inventors: Nahid Ali, Manjarika De, Triparna Sen